These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6984353)

  • 1. The immune response to a chemically induced fibrosarcoma: a comparison of cytolytic T lymphocyte stimulation by transformed and non-transformed fibroblasts.
    Bowlin TL; Proffitt MR
    Cancer Immunol Immunother; 1982; 13(1):30-7. PubMed ID: 6984353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic significance of nonspecific suppressor cells in spleens of tumor-bearing mice.
    Hanna N; Kripke ML
    Cell Immunol; 1979 Mar; 43(2):293-303. PubMed ID: 314343
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells.
    Brunner KT; MacDonald HR; Cerottini JC
    J Immunol; 1980 Apr; 124(4):1627-34. PubMed ID: 6154076
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of growth of malignant cells by anti-idiotypic immunity.
    Schreiber H; Flood PM; Kripke ML; Urban JL
    Haematol Blood Transfus; 1981; 26():368-71. PubMed ID: 6976294
    [No Abstract]   [Full Text] [Related]  

  • 5. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
    Röllinghoff M; Warner NL
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of immunogenic tumors to elicit cytolytic T cells in syngeneic hosts.
    Nelson DS; Hopper KE; Blanden RV; Gardner ID; Kearney R
    Cancer Lett; 1978 Aug; 5(2):61-7. PubMed ID: 308390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the spleen in the immunity to a chemically induced sarcoma in C3H mice.
    Bard DS; Pilch YH
    Cancer Res; 1969 May; 29(5):1125-31. PubMed ID: 5781103
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas.
    Mantovani A; Evans R; Alexander P
    Br J Cancer; 1977 Jul; 36(1):35-40. PubMed ID: 889683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractionation of immune RNA capable of transferring tumor-specific cellular cytotoxicity.
    Wang BS; Mannick JA
    Cell Immunol; 1978 May; 37(2):358-68. PubMed ID: 657284
    [No Abstract]   [Full Text] [Related]  

  • 10. H-2 private specificity of in vivo-sensitized lymphocytes studied by adsorption on fibroblast monolayers.
    Jorgensen PN; Güttler F; Rubin B
    Scand J Immunol; 1975; 4(4):383-9. PubMed ID: 52890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring antibodies against fibrosarcoma and glioma cells in rats.
    Itaya T; Moriuchi T; Kodama T; Sendo F; Kobayashi H
    Gan; 1982 Jun; 73(3):454-61. PubMed ID: 7129010
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytolytic antibodies to methylcholanthrene-induced sarcomas elicited by immunization of syngeneic mice.
    Merino F; Abeyounis CJ; Milgrom F
    Eur J Cancer (1965); 1979 Jun; 15(6):829-35. PubMed ID: 499271
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of cytostasis in antitumor immunity: comparison between syngeneic and allogeneic systems.
    Mitani M; Mori K; Himeno K; Matsumoto T; Taniguchi K; Nomoto K
    Cell Immunol; 1985 Apr; 92(1):22-30. PubMed ID: 4075412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
    Konda S; Smith RT
    Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
    [No Abstract]   [Full Text] [Related]  

  • 16. The stimulatory effects of bearing primary methylcholanthrene-induced tumors upon the murine lymphoreticular system.
    Smith RT; Konda S
    Int J Cancer; 1973 Nov; 12(3):577-88. PubMed ID: 4598649
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte populations participating in cellular antitumor immune responses mediated by immune RNA.
    Kern DH; Chow N; Pilch YH
    J Natl Cancer Inst; 1978 Feb; 60(2):335-44. PubMed ID: 304487
    [No Abstract]   [Full Text] [Related]  

  • 18. EnhancemenT of 3LL tumor growth by autosensitized t lymphocytes independent of the host lymphatic system.
    Carnaud C; Ilfeld D; Levo Y; Trainin N
    Int J Cancer; 1974 Aug; 14(2):168-75. PubMed ID: 4549211
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation-induced changes in established tumor immunity.
    Vaage J; Doroshow JH; DuBois TT
    Cancer Res; 1974 Jan; 34(1):129-37. PubMed ID: 4809453
    [No Abstract]   [Full Text] [Related]  

  • 20. H-2 restriction of the T cell response to chemically induced tumors: evidence from F1 replaced by parent chimeras.
    Lannin DR; Yu S; McKhann CF
    J Immunol; 1982 Jan; 128(1):263-8. PubMed ID: 6459368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.